Clinical Trial Update: COmparison of Xience PrimE Versus REsolute Integrity in Diabetes or Small Vessel Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Xience Prime versus Resolute Integrity drug-eluting stents in patients undergoing coronary angioplasty, including those with diabetes an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Microvascular Disease
• Diabetes Mellitus

Drugs mentioned

• Resolute Integrity
• Xience Prime (everolimus-eluting stent)

Snippet

Sponsor: Chonbuk National University Hospital | Conditions: Angioplasty, Balloon, Coronary | Phase 3 | Status: UNKNOWN